Study number 8539-034
Participants Needed!
Dates
Aug 04 2025-Nov 25 2025
Location
Dallas, Texas
Age
18-65
Gender
Both Males and Females
Smoker
Yes
Compensation
$15,115
Group
C3a OR C3b
Study Details
The investigational drug in this research study is being developed for the treatment of vitiligo, a disease that causes loss of skin color in patches, and related autoimmune disorders. This is the first time that this study drug is being given to humans.
Fortrea Dallas, Tx is recruiting for:
-Healthy Men and Women, age 18-65
-Body Mass Index between 18-32
-Study involves 3 separate stays totaling 12 nights & 10 follow-up visits
-Compensation up to $15,115 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
*Females must be of nonchildbearing potential
Additional Details
Pt B C3a:
Check-in: Aug 4, 18, Sep 1
Check-out: Aug 11, 20, Sep 4
Follow-up: Aug 18, 25, Sep 8, 12, 16, 30, Oct 14, 28, Nov 11, 25,
OR
Pt B C3b:
Check-in: Aug 5, 19, Sep 2
Check-out: Aug 12, 21, Sep 5,
Follow-up: Aug 16, 26, Sep 9, 13, 17, Oct 1, 15, 29, Nov 12, 26